History
A list of downloadable documents created during development.
Background information
Renal cell carcinoma (advanced) - axitinib: equality impact assessment
Renal cell carcinoma (advanced) - axitinib [ID518]: 2nd final appraisal determination
Renal cell carcinoma (advanced) - axitinib: appraisal consultation 2
-
Renal cell carcinoma (advanced) - axitinib: appraisal consultation 2
Renal cell carcinoma (advanced) - axitinib: final scope (post-appeal)
Renal cell carcinoma (advanced) - axitinib: final matrix (post-appeal)
Renal cell carcinoma (advanced) - axitinib: response to consultee and commentator comments on the updated scope and provisional matrix (post-appeal)
Renal cell carcinoma (advanced) - axitinib: appeal
Renal cell carcinoma (advanced) - axitinib: final appraisal determination
-
Renal cell carcinoma (advanced) - axitinib: consultee and commentator comments on the ACD
Renal cell carcinoma (advanced) - axitinib: appraisal consultation
-
Renal cell carcinoma (advanced) - axitinib: appraisal consultation
-
Renal cell carcinoma (advanced) - axitinib: Evaluation report
-
Renal cell carcinoma (advanced) - axitinib: Manufacturer submission
-
Renal cell carcinoma (advanced) - axitinib: Clarification
-
Renal cell carcinoma (advanced) - axitinib: Patient group, professional group and NHS organisation submission statements
-
Renal cell carcinoma (advanced) - axitinib: Expert written personal statements